Importance de la PCR dans la gestion d’une épidémie à Mycoplasma pneumoniae au centre hospitalier de Béthune (Pas-de-Calais)

by Dekeyser, S., Bonnel, C., Martinet, A., Descamps, D.
Published in Pathol Biol (Paris) (2011)

Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy

by Marcelin, AG, Charpentier, C, Wirden, M, Descamps, D, Calvez, V
Published 2010

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens

by Marcelin, AG, Charpentier, C, Ferreira, C, Wirden, M, Lemarchand, C, Descamps, D, Calvez, V
Published 2010

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 As...

by Damond, F., Roquebert, B., Bénard, A., Collin, G., Miceli, M., Yéni, P., Brun-Vezinet, F., Descamps, D.
Published 2007

Persistence of immune responses to the HPV-16/18 AS04-adjuvanted vaccine in women aged 15–55 years and first-time modelling of antibody responses in mature women: results from an o...

by Schwarz, T, Spaczynski, M, Kaufmann, A, Wysocki, J, Gałaj, A, Schulze, K, Suryakiran, P, Thomas, F, Descamps, D
Published in BJOG (2015)

A28 Phylogeographic analysis of HIV-2 ANRS CO5 cohort reveals new trends in HIV-2 epidemic patterns in West Africa

by Visseaux, B, Bertine, M, Storto, A, Damond, F, Collin, F, Chêne, G, Matheron, S, Charpentier, C, Hué, S, Descamps, D
Published in Virus Evol (2018)

Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

by Descamps, D, Collin, G, Letourneur, F, Apetrei, C, Damond, F, Loussert-Ajaka, I, Simon, F, Saragosti, S, Brun-Vézinet, F
Published 1997

Caractéristiques cliniques et paracliniques de 4 patients confirmés à COVID-19

by Parisey, M., Le Pluart, D., Deconinck, L., Bouadma, L., Patrier, J., Houhou-Fidouh, N., Descamps, D., Lescure, F., Yazdanpanah, Y.
Published in Med Mal Infect (2020)

Description des cas possibles de COVID-19 dans un établissement de santé de référence

by Souhail, B., Valayer, S., Parisey, M., Le Pluart, D., Ismael, S., Dubert, M., Rioux, C., Descamps, D., Lescure, F.-X., Yazdanpanah, Y.
Published in Med Mal Infect (2020)

Real-time determination of enantiomeric and isomeric content using photoelectron elliptical dichroism

by Comby, A., Bloch, E., Bond, C. M. M., Descamps, D., Miles, J., Petit, S., Rozen, S., Greenwood, J. B., Blanchet, V., Mairesse, Y.
Published in Nat Commun (2018)

Impact de la pandémie de COVID-19 sur les populations sans domicile fixe : résultats d’une cohorte fermée rétrospective (mars–mai 2020)

by Husain, M., Rachline, A., Cousien, A., Rolland, S., Ferre, V., Wicky-Thisse, M., Descamps, D., Yazdanpanah, Y., Charpentier, C., Pasquet-Cadre, A.
Published in Infect Dis Now (2021)

Polymorphism of the Human Immunodeficiency Virus Type 2 (HIV-2) Protease Gene and Selection of Drug Resistance Mutations in HIV-2-Infected Patients Treated with Protease Inhibitors

by Damond, F., Brun-Vezinet, F., Matheron, S., Peytavin, G., Campa, P., Pueyo, S., Mammano, F., Lastere, S., Farfara, I., Simon, F., Chene, G., Descamps, D.
Published 2005

Optics-less focusing of XUV high-order harmonics

by Quintard, L., Strelkov, V., Vabek, J., Hort, O., Dubrouil, A., Descamps, D., Burgy, F., Péjot, C., Mével, E., Catoire, F., Constant, E.
Published in Sci Adv (2019)

Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère

by Peiffer-Smadja, N., Bridier-Nahmias, A., Carpentier, C., Garé, M., Rioux, C., Allemand, A., Kramer, L., Descamps, D., Yazdanpanah, Y., Visseaux, B.
Published in Infect Dis Now (2021)

HIV-1 Dynamics and Coreceptor Usage in Maraviroc-Treated Patients with Ongoing Replication

by Recordon-Pinson, P., Raymond, S., Bellecave, P., Marcelin, A. G., Soulie, C., Descamps, D., Calvez, V., Harrigan, P. R., Fleury, H., Izopet, J., Masquelier, B.
Published 2013

Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during Pregnancy

by Pain, J. B., Lê, M. P., Caseris, M., Amiel, C., Lassel, L., Charpentier, C., Desnoyer, A., Farnoux, C., Pialoux, G., Descamps, D., Peytavin, G.
Published in Antimicrob Agents Chemother (2015)

Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

by Schuurman, R, Descamps, D, Weverling, G J, Kaye, S, Tijnagel, J, Williams, I, van Leeuwen, R, Tedder, R, Boucher, C A, Brun-Vezinet, F, Loveday, C
Published 1996

Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification

by Damond, F., Avettand-Fenoel, V., Collin, G., Roquebert, B., Plantier, J. C., Ganon, A., Sizmann, D., Babiel, R., Glaubitz, J., Chaix, M. L., Brun-Vezinet, F., Descamps, D., Rouzioux, C.
Published 2010

Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre

by Peiffer-Smadja, N., Lucet, J.-C., Bendjelloul, G., Bouadma, L., Gerard, S., Choquet, C., Jacques, S., Khalil, A., Maisani, P., Casalino, E., Descamps, D., Timsit, J.-F., Yazdanpanah, Y., Lescure, F.-X.
Published in Clin Microbiol Infect (2020)

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

by Larrouy, Lucile, Chazallon, C., Landman, R., Capitant, C., Peytavin, G., Collin, G., Charpentier, C., Storto, A., Pialoux, G., Katlama, C., Girard, P. M., Yeni, P., Aboulker, J. P., Brun-Vezinet, F., Descamps, D.
Published 2010